End-To-End Process for Improved Purity and Analytics of LNP-Based Therapeutics

Thank you - Your Download is Available Below

End-To-End Process for Improved Purity and Analytics of LNP-Based Therapeutics

PDF | 828.2 KB

End-To-End Process for Improved Purity and Analytics of LNP-Based Therapeutics

The mRNA-LNP production process involves four key steps: in most of the cases expressing plasmid DNA in E. coli, linearizing and purifying the pDNA, synthesizing mRNA through in-vitro transcription, purifying the mRNA, and encapsulating nucleic acids into lipid nanoparticles (LNPs) for effective delivery of mRNA vaccines and therapies.

Clear form data

Please Complete the Form

First Name *

Last Name *

Email *

Phone Number *

Company *

Job Title *

Address *

Country *

Postal Code *

I would like to sign up for newsletters from Sartorius (Sartorius AG and its affiliated companies) based of my personal interests.
I can revoke my consent at any time with effect for the future by sending an e-mail to unsubscribe@sartorius.com or by clicking on the "unsubscribe" link in e-mails I have received.

* These fields are required Information on the use of your data can be found in our privacy policy

Thank you - Your Download is Available Below

End-To-End Process for Improved Purity and Analytics of LNP-Based Therapeutics

End-To-End Process for Improved Purity and Analytics of LNP-Based Therapeutics

Please Complete the Form

Complete Form to Access the File